Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Aclaris Therapeutics, Inc. (ACRS) had Return on Equity of -17.26% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.63M |
|
$-21.50M |
|
$1.45M |
|
$0.18M |
|
$25.87M |
|
$-24.24M |
|
$2.73M |
|
$-21.50M |
|
$-21.50M |
|
$-21.50M |
|
$-21.50M |
|
$-21.50M |
|
$-21.50M |
|
$-24.24M |
|
$-24.13M |
|
142.74M |
|
142.74M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$97.77M |
|
$0.66M |
|
$81.93M |
|
$179.69M |
|
$28.24M |
|
-- |
|
$26.87M |
|
$55.11M |
|
$124.58M |
|
$124.58M |
|
$124.58M |
|
139.82M |
|
| Cash Flow Statement Financials | |
$-38.00M |
|
$-20.67M |
|
$57.87M |
|
$19.96M |
|
$19.17M |
|
$-0.79M |
|
$5.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.80% |
|
-1487.91% |
|
-1487.91% |
|
-- |
|
-1320.13% |
|
-1320.13% |
|
$-38.07M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.26 |
|
343.04 |
|
|
Return on Equity |
-17.26% |
-17.26% |
|
-11.97% |
|
-17.26% |
|
$0.89 |
|
$-0.27 |
|
$-0.27 |
|